The Last Disease Z

Bublig · 2026 · $8.99 · Action · deal grade A

Measured on 2026-08-30 03:35 UTC. The whole catalog is re-measured daily; a game that just launched can move fast between passes.

• Estimated net residual revenue: $4.5k to $6.8k per month
• Opportunity: $7.3k per month at x1.30 dormancy
• Estimated lifetime owners: 3.0k
• 57%% positive across 75 reviews · 75.0 reviews/month

Why it's flagged

• Developer active, last post 0 months ago
• Last build shipped 0 months ago
• Store page localized in only 2 language(s)

Analyst notes (AI-assisted)

Note written 2026-08-28; the live figures above take precedence over any numbers in it.

The Last Disease Z is an early-access survival-crafting game with zombies, base building, and cooperative multiplayer set in a low-poly open world.

This title sits in a crowded survival-crafting niche dominated by established franchises (DayZ, Rust), yet maintains modest residual revenue with a small but engaged core audience. The polarized review sentiment reflects typical EA growing pains: core systems work, but content density, balance, and UX need substantial iteration before it can compete for mainstream attention. Most relevant for publishers seeking a dormant catalog title with low upside but stable margins, or for a developer evaluating technical debt and player feedback loops on a shoestring budget. Most realistic play: watch.

• Risk: Survival-crafting genre is saturated; differentiation versus DayZ, Rust, and Valheim is minimal and not yet evident to players.
• Risk: Persistent reports of UI clutter, audio imbalance, balance tuning (9000 HP boss vs 12 damage axe), and save-file corruption suggest architectural debt.
• Risk: Heavy reliance on community guidance (hidden crafting recipes, remote map resources) indicates poor onboarding and world design communication.

This case as Markdown · Estimates carry ±30-50%% error per title.